| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Veradermics IncMANE | $116.80 | Strong Buy | $182.00 | +55.82% | 18 hours ago | |
Analyst RankingTop 15% #780 out of 5315 analysts Average Return+20.58% Win Rate46%28 out of 61 Risk vs RewardPoor Good Analyst ColorJefferies's Roger Song raised their price target on Veradermics (NYSE: MANE) by 31.9% from $138 to $182 on 2026/07/07. The analyst maintained their Strong Buy rating on the stock. Song attributed their price target hike on Veradermics to their belief that the VDPHL01 Phase 2 female pattern hair loss readout due in 2026/07 will be the "next major value-driver" because of the "stellar" Phase 3 male topline results. The analyst called the upcoming readout a "high-conviction de-risking event." | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||